Skip to main content

Table 3 Time to fourth injection between two groups

From: Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial

Variable Median (IQR)a

IVR (N = 30)

IVR + Laser (N = 34)

P value for group difference

Time to fourth injection

28 (8, 40)

12 (8, 40)

0.1056

  1. aAs time to fourth injection in two groups were abnormally distributed, median (IQR) and Wilcoxon analysis were used